ArticleBreast care (Basel, Switzerland)2021

Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).

Annelot G J van Rossum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.